Reducing Timelines Through Strategic Outsourcing

pharmafile | June 7, 2012 | Feature | Research and Development |   

Frank Lis, Vice President & General Manager, Clinical Supply Services, explores the general effects brought on by the consolidation of pharmaceutical companies, increased generic competition, growth in the biologics arena, and  the shift of clinical trial studies outside the US. On the heels of the Aptuit Clinical Trial Services acquisition, Catalent invites you to review the results of a recent “double-blind” study, established market trends and take an exclusive look into clinical service industry changes. Click the link below to download full report.

http://solutions.catalent.com/FrankLisPresentation?elq=76e266504b0348d0b1db5cc372f295b1&elqCampaignId=155